Company

Vicore Pharma Holding AB

Headquarters: Gothenburg, Sweden

Employees: 21

OMX: VICO

Market Cap

kr2.13 Billion

SEK as of July 1, 2024

US$201.1 Million

Market Cap History

Vicore Pharma Holding AB market capitalization over time

Evolution of Vicore Pharma Holding AB market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Vicore Pharma Holding AB

Detailed Description

Vicore Pharma Holding AB (publ) engages in the research and development of pharmaceutical products for the treatments for rare lung diseases. The company is developing VP01, a small molecule compound for oral administration that is in phase II clinical trial for the treatment of interstitial lung diseases, idiopathic pulmonary fibrosis (IPF), systemic sclerosis, and COVID-19; and VP02, a formulation and delivery route for an existing immunomodulatory compound, which is preclinical trials to treat patients with IPF. It has a cooperation and development agreement with Emeriti Bio AB; license agreement with Nanologica AB (publ); and a collaboration agreement with Alex Therapeutics AB for the development and clinical validation of a digital therapeutic (DTx) built on the Alex DTx platform. The company was formerly known as Mintage Scientific AB. Vicore Pharma Holding AB (publ) was founded in 2000 and is headquartered in Gothenburg, Sweden.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Vicore Pharma Holding AB has the following listings and related stock indices.


Stock: OMX: VICO wb_incandescent

Stock: FSX: 6Y4 wb_incandescent

Details

Headquarters:

Kronhusgatan 11

Gothenburg, 411 05

Sweden

Phone: 46 3 17 88 05 60